These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24262199)

  • 1. Blood-based biomarkers for Parkinson's disease.
    Chahine LM; Stern MB; Chen-Plotkin A
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1(0 1):S99-103. PubMed ID: 24262199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Profiling of Exosomal Proteins for Blood-based Biomarkers in Parkinson's Disease.
    Kitamura Y; Kojima M; Kurosawa T; Sasaki R; Ichihara S; Hiraku Y; Tomimoto H; Murata M; Oikawa S
    Neuroscience; 2018 Nov; 392():121-128. PubMed ID: 30266682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood biomarkers with Parkinson's disease clusters and prognosis: The oxford discovery cohort.
    Lawton M; Baig F; Toulson G; Morovat A; Evetts SG; Ben-Shlomo Y; Hu MT
    Mov Disord; 2020 Feb; 35(2):279-287. PubMed ID: 31693246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI Study.
    Koros C; Simitsi AM; Papadimitriou D; Bougea A; Prentakis A; Papagiannakis N; Pachi I; Bozi M; Antonelou R; Angelopoulou E; Beratis I; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2020; 10(2):481-487. PubMed ID: 32176655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.
    Shi M; Zabetian CP; Hancock AM; Ginghina C; Hong Z; Yearout D; Chung KA; Quinn JF; Peskind ER; Galasko D; Jankovic J; Leverenz JB; Zhang J
    Neurosci Lett; 2010 Aug; 480(1):78-82. PubMed ID: 20540987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.
    Eidson LN; Kannarkat GT; Barnum CJ; Chang J; Chung J; Caspell-Garcia C; Taylor P; Mollenhauer B; Schlossmacher MG; Ereshefsky L; Yen M; Kopil C; Frasier M; Marek K; Hertzberg VS; Tansey MG
    J Neuroinflammation; 2017 Aug; 14(1):164. PubMed ID: 28821274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease.
    Fan Z; Pan YT; Zhang ZY; Yang H; Yu SY; Zheng Y; Ma JH; Wang XM
    J Neuroinflammation; 2020 Jan; 17(1):11. PubMed ID: 31915018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for Parkinson's Disease: How Good Are They?
    Li T; Le W
    Neurosci Bull; 2020 Feb; 36(2):183-194. PubMed ID: 31646434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted discovery and validation of plasma biomarkers of Parkinson's disease.
    Pan C; Zhou Y; Dator R; Ginghina C; Zhao Y; Movius J; Peskind E; Zabetian CP; Quinn J; Galasko D; Stewart T; Shi M; Zhang J
    J Proteome Res; 2014 Nov; 13(11):4535-45. PubMed ID: 24853996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.
    Delgado-Alvarado M; Gago B; Gorostidi A; Jiménez-Urbieta H; Dacosta-Aguayo R; Navalpotro-Gómez I; Ruiz-Martínez J; Bergareche A; Martí-Massó JF; Martínez-Lage P; Izagirre A; Rodríguez-Oroz MC
    Mov Disord; 2017 Jul; 32(7):1066-1073. PubMed ID: 28548309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific splice variants are associated with Parkinson's disease.
    Santiago JA; Scherzer CR; ; Potashkin JA
    Mov Disord; 2013 Oct; 28(12):1724-7. PubMed ID: 24108702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease biomarkers based on α-synuclein.
    Fayyad M; Salim S; Majbour N; Erskine D; Stoops E; Mollenhauer B; El-Agnaf OMA
    J Neurochem; 2019 Sep; 150(5):626-636. PubMed ID: 31265130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson's disease. Scientific commentary on: "Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease".
    Shebl N; Salama M
    Acta Neuropathol; 2024 May; 147(1):88. PubMed ID: 38761253
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha-Synuclein as a Biomarker for Parkinson's Disease.
    Atik A; Stewart T; Zhang J
    Brain Pathol; 2016 May; 26(3):410-8. PubMed ID: 26940058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Metabolomics-Based Biomarker Research for Parkinson's Disease.
    Li X; Fan X; Yang H; Liu Y
    Mol Neurobiol; 2022 Feb; 59(2):1041-1057. PubMed ID: 34826053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.
    Dong MX; Hu L; Wei YD; Chen GH
    Neurosci Lett; 2021 Feb; 745():135626. PubMed ID: 33440238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling.
    Zhao H; Wang C; Zhao N; Li W; Yang Z; Liu X; Le W; Zhang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():101-108. PubMed ID: 29518718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.
    Hong Z; Shi M; Chung KA; Quinn JF; Peskind ER; Galasko D; Jankovic J; Zabetian CP; Leverenz JB; Baird G; Montine TJ; Hancock AM; Hwang H; Pan C; Bradner J; Kang UJ; Jensen PH; Zhang J
    Brain; 2010 Mar; 133(Pt 3):713-26. PubMed ID: 20157014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease.
    Trupp M; Jonsson P; Ohrfelt A; Zetterberg H; Obudulu O; Malm L; Wuolikainen A; Linder J; Moritz T; Blennow K; Antti H; Forsgren L
    J Parkinsons Dis; 2014; 4(3):549-60. PubMed ID: 24927756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Parkinson's Disease through the Peptoid Recognizing α-Synuclein in Serum.
    Gao H; Zhao Z; He Z; Wang H; Liu M; Hu Z; Cheng O; Yang Y; Zhu L
    ACS Chem Neurosci; 2019 Mar; 10(3):1204-1208. PubMed ID: 30682886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.